A Case of Metastatic Non-small Cell Lung Adenocarcinoma and Metachronous Primary Hepatocellular Carcinoma

被引:1
作者
Sidhom, Fady [1 ]
Ali, Ahmed [2 ]
Ibrahim, Mohd Elmugtaba [1 ]
机构
[1] Howard Univ Hosp, Internal Med, Washington, DC 20060 USA
[2] Howard Univ Hosp, Med Oncol, Washington, DC USA
关键词
transarterial embolization; next generation sequencing (ngs); multiple primary malignant neoplasm; non-small cell lung carcinoma (nsclc); hepatocellular carcinoma (hcc); multiple primary neoplasms; OSIMERTINIB; MUTATIONS;
D O I
10.7759/cureus.20185
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple primary malignant neoplasms (MPMNs) are generally defined as the co-occurrence of primary neoplasms of distinct histology in the same individual. Second and higher-order primary malignancies now comprise about 18% of all cancer incidence in the United States. Specifically in female cancer survivors, the incidence ratio of developing multiple primary cancers (MPCs) is 1.2 to 1.6. Patients with lung cancer are at higher risk to develop a second malignancy compared to the general population. However, the coexistence of non-small cell lung adenocarcinoma and primary hepatocellular carcinoma (HCC) is not described in the literature. Here we describe a rare case of a 69-year-old female with non-small cell lung adenocarcinoma with vertebral metastasis that developed primary HCC.
引用
收藏
页数:6
相关论文
共 8 条
[1]  
[Anonymous], 2006, NIH publication
[2]   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].
Lynch, TJ ;
Bell, DW ;
Sordella, R ;
Gurubhagavatula, S ;
Okimoto, RA ;
Brannigan, BW ;
Harris, PL ;
Haserlat, SM ;
Supko, JG ;
Haluska, FG ;
Louis, DN ;
Christiani, DC ;
Settleman, J ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139
[3]   Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer [J].
Mok, T. S. ;
Wu, Y. -L. ;
Ahn, M. -J. ;
Garassino, M. C. ;
Kim, H. R. ;
Ramalingam, S. S. ;
Shepherd, F. A. ;
He, Y. ;
Akamatsu, H. ;
Theelen, W. S. M. E. ;
Lee, C. K. ;
Sebastian, M. ;
Templeton, A. ;
Mann, H. ;
Marotti, M. ;
Ghiorghiu, S. ;
Papadimitrakopoulou, V. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) :629-640
[4]   Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses [J].
Rognoni, Carla ;
Ciani, Oriana ;
Sommariva, Silvia ;
Facciorusso, Antonio ;
Tarricone, Rosanna ;
Bhoori, Sherrie ;
Mazzaferro, Vincenzo .
ONCOTARGET, 2016, 7 (44) :72343-72355
[5]   Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer [J].
Soria, J. -C. ;
Ohe, Y. ;
Vansteenkiste, J. ;
Reungwetwattana, T. ;
Chewaskulyong, B. ;
Lee, K. H. ;
Dechaphunkul, A. ;
Imamura, F. ;
Nogami, N. ;
Kurata, T. ;
Okamoto, I. ;
Zhou, C. ;
Cho, B. C. ;
Cheng, Y. ;
Cho, E. K. ;
Voon, P. J. ;
Planchard, D. ;
Su, W. -C. ;
Gray, J. E. ;
Lee, S. -M. ;
Hodge, R. ;
Marotti, M. ;
Rukazenkov, Y. ;
Ramalingam, S. S. ;
Boyer, Michael ;
Lee, Chee ;
Hughes, Brett ;
O'Byrne, Kenneth ;
Briggs, Peter ;
Milward, Michael ;
John, Thomas ;
Demedts, Ingel ;
Vansteenkiste, Johan ;
Bustin, Frederique ;
Barrios, Carlos Henrique ;
Timcheva, Constanta ;
Butts, Charles ;
Goss, Glenwood ;
Juergens, Rosalyn ;
Leighl, Natasha ;
Cheng, Susanna ;
Burkes, Ronald ;
Zhou, Caicun ;
Zhang, Helong ;
Shu, Yongqian ;
Cheng, Ying ;
Zhou, Qing ;
Li, Wei ;
Feng, Guosheng ;
He, Yong .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02) :113-125
[6]   Multiple primary tumours: challenges and approaches, a review [J].
Vogt, Alexia ;
Schmid, Sabine ;
Heinimann, Karl ;
Frick, Harald ;
Herrmann, Christian ;
Cerny, Thomas ;
Omlin, Aurelius .
ESMO OPEN, 2017, 2 (02)
[7]  
Warren S, 1944, CANCER RES, V4, P554
[8]   Effectiveness of Tyrosine Kinase Inhibitors on "Uncommon" Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non-Small Cell Lung Cancer [J].
Wu, Jenn-Yu ;
Yu, Chong-Jen ;
Chang, Yeun-Chung ;
Yang, Chih-Hsin ;
Shih, Jin-Yuan ;
Yang, Pan-Chyr .
CLINICAL CANCER RESEARCH, 2011, 17 (11) :3812-3821